With a rising number of COVID-19 cases throughout the county, DHR Health and DHR Health Institute for Research and Development have partnered with other hospitals in the region to establish a novel protocol to treat severe and life-threatening COVID-19 patients using plasma from donors who have recovered from COVID-19 infection.
It has been previously documented that plasma from patients who have recovered from COVID-19 infection contains antibodies that may help fight the disease, according to a news release from DHR.
Using FDA approved guidelines, plasma from selected donors will be collected using plasmapheresis at identified blood donation centers in the Rio Grande Valley through partnerships with blood donation facilities in McAllen and Harlingen.
This protocol has also been reviewed and approved by the DHR Health Institute for Research and Development, Institutional Review Board to ensure compliance with federal and state regulations involving human research subjects, the release stated
“This is a unique opportunity for individuals who have recovered from COVID-19 infection to help patients who are suffering from severe or life-threatening COVID-19,” the release stated.
Donors will be provided with a modest financial stipend to participate in this study.